Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1002617

registered interest
date	06/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps through the new long-term NHS plan to (a) support people throughout and (b) improve their experience of (i) treatment and (ii) living with cancer.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	188811
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>The NHS Long Term Plan provides an excellent opportunity to look at how cancer and other services can be further improved over the next decade. The plan is currently in development and will be published later in the year.</p><p> </p><p>The independent Cancer Taskforce identified establishing patient experience on a par with clinical effectiveness and safety and transforming our approach to support people living with and beyond cancer as strategic priorities in the report ‘Achieving World-class Cancer Outcomes: A Strategy for England, 2015-2020’. In December 2016, NHS England announced a fund of over £200 million available to Cancer Alliances over the next two years, specifically to support those areas of the strategy that they estimated would need significant investment, including to help patients living with and beyond cancer.</p><p> </p><p>As part of that programme of work, the Recovery Package is being commissioned and delivered in full or in part by many clinical commissioning groups and providers across England. NHS England’s aim is to accelerate the process to ensure full implementation by 2020 so the package will be available to all cancer patients across the country regardless of location. Alongside this, NHS England is building up a picture of current provision to help target future work to support rollout.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 188812 question first answered 12/11/2018 17:21:03 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1002618

registered interest
date	06/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to support Cancer Alliances to continue delivering elements of the recovery package to improve long-term support for people who have had cancer.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	188812
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>The NHS Long Term Plan provides an excellent opportunity to look at how cancer and other services can be further improved over the next decade. The plan is currently in development and will be published later in the year.</p><p> </p><p>The independent Cancer Taskforce identified establishing patient experience on a par with clinical effectiveness and safety and transforming our approach to support people living with and beyond cancer as strategic priorities in the report ‘Achieving World-class Cancer Outcomes: A Strategy for England, 2015-2020’. In December 2016, NHS England announced a fund of over £200 million available to Cancer Alliances over the next two years, specifically to support those areas of the strategy that they estimated would need significant investment, including to help patients living with and beyond cancer.</p><p> </p><p>As part of that programme of work, the Recovery Package is being commissioned and delivered in full or in part by many clinical commissioning groups and providers across England. NHS England’s aim is to accelerate the process to ensure full implementation by 2020 so the package will be available to all cancer patients across the country regardless of location. Alongside this, NHS England is building up a picture of current provision to help target future work to support rollout.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 188811 question first answered 12/11/2018 17:21:03 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin

1002675

registered interest
date	06/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the decision on the future of the National Cancer Patient Experience Survey in relation to the National Data Guardian opt-out beyond 2018.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	188813
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>We are giving careful consideration to the application of the national data opt-out to the national cancer patient experience survey as stated in the Government’s response to the National Data Guardian Review July 2017 and other national patient experience surveys. This includes looking at the potential advantages and disadvantages of the national data opt-out not applying to these surveys beyond 2018/19.</p><p> </p><p>In spring 2018 we confirmed that for 2018/2019 the national data opt-out would not be applied to the national cancer patient experience survey and other patient experience surveys. A decision regarding application of the national data opt-out to these surveys beyond 2018/19 will be communicated in due course.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 188814 question first answered 12/11/2018 15:40:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4056 label Biography information for Nic Dakin

1002676

registered interest
date	06/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of enabling the National Cancer Patient Experience Survey to be exemption from the national data guardian opt out after 2018.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	188814
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>We are giving careful consideration to the application of the national data opt-out to the national cancer patient experience survey as stated in the Government’s response to the National Data Guardian Review July 2017 and other national patient experience surveys. This includes looking at the potential advantages and disadvantages of the national data opt-out not applying to these surveys beyond 2018/19.</p><p> </p><p>In spring 2018 we confirmed that for 2018/2019 the national data opt-out would not be applied to the national cancer patient experience survey and other patient experience surveys. A decision regarding application of the national data opt-out to these surveys beyond 2018/19 will be communicated in due course.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 188813 question first answered 12/11/2018 15:40:43 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4056 label Biography information for Nic Dakin

1002186

registered interest
date	05/11/2018
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Discretionary Housing Payments: North Lincolnshire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, pursuant to Answer of 5 November to Question 907432, how much discretionary housing payment was (a) awarded to and (b) spent by North Lincolnshire Council in each of the last three years.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	188225
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>The table below shows the amount awarded to and spent by North Lincolnshire Council in Discretionary Housing Payments in the last 3 financial years:</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Awarded</strong></p></td><td><p><strong>Spent</strong></p></td></tr><tr><td><p>2015/16</p></td><td><p>£240,930</p></td><td><p>£39,626</p></td></tr><tr><td><p>2016/17</p></td><td><p>£294,816</p></td><td><p>£50,735</p></td></tr><tr><td><p>2017/18</p></td><td><p>£395,413</p></td><td><p>£84,105</p></td></tr></tbody></table><p><strong> </strong></p><p>Figures on the amount of Discretionary Housing Payments awarded to and spent by Local Authorities are available:</p><p><br><a href="https://www.gov.uk/government/collections/discretionary-housing-payments-statistics" target="_blank">https://www.gov.uk/government/collections/discretionary-housing-payments-statistics</a></p><p> </p> answering member constituency North Swindon answering member printed Justin Tomlinson question first answered 12/11/2018 14:41:35 answering member 4105 label Biography information for Justin Tomlinson
tabling member	4056 label Biography information for Nic Dakin

999722

registered interest
date	01/11/2018
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Personal Independence Payment: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, how many people with (a) leukaemia, (b) myeloma, (c) Hodgkin’s lymphoma and (d) non-Hodgkin’s lymphoma are in receipt of personal independence payment.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	187016
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>The Department publishes a range of detailed statistics for Personal Independence Payment (PIP) on Stat-Xplore: <a href="https://stat-xplore.dwp.gov.uk/" target="_blank">https://stat-xplore.dwp.gov.uk/</a>. Guidance on how to use Stat-Xplore can be found here: <a href="https://sw.stat-xplore.dwp.gov.uk/webapi/online-help/index.html" target="_blank">https://sw.stat-xplore.dwp.gov.uk/webapi/online-help/index.html</a>.</p><p>These statistics include monthly caseloads (claims in payment) for claimants of PIP broken down by disability including leukaemia, myeloma, Hodgkin’s and non-Hodgkin’s lymphoma.</p> answering member constituency Truro and Falmouth answering member printed Sarah Newton question first answered 12/11/2018 12:07:28 answering member 4071 label Biography information for Sarah Newton
tabling member	4056 label Biography information for Nic Dakin

999725

registered interest
date	01/11/2018
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Personal Independence Payment: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, how many people with (a) leukaemia, (b) myeloma, (c) Hodgkin's lymphoma and (d) non-Hodgkin's lymphoma have (i) been reassessed from disability living allowance to personal independence payment and (ii) received reduced rates of award.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	187018
answer	answer is ministerial correction date of answer 12/11/2018 answer text <p>Personal Independence Payment (PIP) has different eligibility criteria to Disability Living Allowance (DLA), and takes a more holistic view of a person’s health condition or disability and the impact it has on their ability to live an independent life. Therefore, when a DLA claimant is invited to claim PIP and is reassessed, the level of their award may stay the same, go up, down or cease altogether depending on their assessed level of need. It is important to note that the claimant may no longer have the condition recorded in the DLA system when they apply for PIP.</p><p>We introduced PIP to replace the outdated DLA system. PIP is a fairer benefit, which takes a much wider look at the way an individual’s health condition or disability impacts them on a daily basis. Under PIP, 30 per cent of claimants are receiving the highest possible support, compared with just 15 per cent under DLA.</p><p><strong> </strong></p><p>3,480 DLA claimants with Leukaemia have been reassessed from DLA to PIP and of this 1,080 received a reduced award amount on PIP compared to DLA, 840 were disallowed PIP post referral to the Assessment Provider and 140 were disallowed PIP pre-referral to the Assessment Provider.</p><p> </p><p>520 DLA claimants with Myeloma have been reassessed from DLA to PIP and of this 200 received a reduced award amount on PIP compared to DLA, 70 were disallowed PIP post referral to the Assessment Provider and 10 were disallowed PIP pre-referral to the Assessment Provider.</p><p> </p><p>300 DLA claimants with Hodgkin's lymphoma have been reassessed from DLA to PIP and of this 100 received a reduced award amount on PIP compared to DLA, 90 were disallowed PIP post referral to the Assessment Provider and 20 were disallowed PIP pre-referral to the Assessment Provider.</p><p> </p><p>660 DLA claimants with non-Hodgkin's lymphoma have been reassessed from DLA to PIP and of this 240 received a reduced award amount on PIP compared to DLA, 160 were disallowed PIP post referral to the Assessment Provider and 20 were disallowed PIP pre-referral to the Assessment Provider.</p><p> </p><p><strong>Notes</strong></p><ul><li>The category “Leukaemia” includes 6 categories under the DLA computer system - Leukaemia - myelogenous (myeloid) acute, Leukaemia - lymphoblastic – acute, Leukaemia - myeloid - chronic, Leukaemia - lymphocytic – chronic, Leukaemias - Other / type not known, Cancer and Leukaemia.</li><li>The PIP Reassessment outcome is the outcome of the first DWP decision on each reassessment claim (i.e. prior to any reconsideration, appeal action and award review), where that decision was made between 1st October 2013 and 31st October 2017.</li><li>Claimants that withdrew their claim to PIP are excluded.</li><li>DLA Entitlement is the DLA award at the time of PIP reassessment registration.</li><li>Reassessment outcomes are for individuals who were aged 16 to 64 on 8th April 2013.</li><li>Data includes PIP claims made under both Normal Rules and Special Rules for the Terminally Ill. However, under DLA a claimant can be recorded as “Terminally Ill” rather than as having a named disability. Therefore, such cases are excluded from the above figures.</li><li>The statistics provided relate to DLA award levels so primary disabling condition is reported as recorded on the DLA computer system. Claimants may often have multiple disabling conditions upon which the decision is based but only the primary condition is shown in these statistics.</li><li>Primary disabling condition may be recorded differently on the PIP and DLA computer systems.</li><li>Figures are rounded to the nearest 10.</li><li>Great Britain only.</li></ul> answering member constituency Truro and Falmouth answering member printed Sarah Newton question first answered 12/11/2018 12:15:49 answering member 4071 label Biography information for Sarah Newton
tabling member	4056 label Biography information for Nic Dakin